This website uses cookies to improve your experience. Learn more about cookies and how to manage them.



Society opens applications for new Inclusive Pharmacology Education Steering Group

13 Apr 2021

Following the launch of our Vision for equality, diversity and inclusion, we will be supporting inclusive pharmacology education as a priority for 2021. We have set up an inclusive pharmacology steering group to guide these activities. Find out how to apply.

MHRA issues new advice regarding Oxford-AstraZeneca COVID-19 vaccine

07 Apr 2021

Society President Professor Sir Munir Pirmohamed spoke today at a press conference about the Oxford-Astra Zeneca COVID-19 vaccine, and outlined the new advice.  

Society welcomes new GMC guidance on prescribing and managing medicines and devices

05 Apr 2021

Today, 5 April 2021, updated guidance on good practice in prescribing and managing medicines and devices, published by the General Medical Council (GMC) comes into force. The guidance supports doctors to be able to prescribe safely for their patients, regardless of the setting. It sets out the GMC standards for good practice when prescribing, either face-to-face or remotely. The guidance also responds to the increase in remote consultations which has come as a result of the COVID-19 pandemic.  

Society joins calls to protect UK R&D funding

01 Apr 2021

The Society joins others in the sector in urging government to protect R&D budgets.

Society partners with Zinc Media for film series

31 Mar 2021

The British Pharmacological Society have partnered with Zinc Media to produce a series of complementary and informative films. These films will celebrate innovation and collaboration across the industry, and highlight the impact this has on millions in the pursuit for patient health.   The COVID-19 pandemic has garnered considerable interest in our profession. Through this partnership with Zinc Media we will tell the stories of the people within it. We will be profiling various career...

Society welcomes new Scottish Heart Disease: Action Plan

29 Mar 2021

The Society welcomes publication of the Scottish Government’s new ‘Heart disease: action plan’. The action plan sets out the Government’s priorities and the actions they will take to minimise preventable heart disease and ensure equitable and timely treatment for people with suspected heart disease in Scotland.  

Investing in UK clinical pharmacology will save and improve lives

23 Mar 2021

The Society, as part of the Clinical Pharmacology Skills Alliance (CPSA), welcomes the UK-wide government vision -  “Saving and improving lives: the future of UK clinical research delivery” - that aims to “to create a patient-centred, pro-innovation and digitally enabled clinical research environment, which empowers everyone across the NHS to participate in delivering research and ensures that patients from across the UK are supported to take part in research that is of relevance to them”.

International Women's Day: Celebration and challenge

04 Mar 2021

The Society celebrates International Women's Day.

New treatment for acute hepatic porphyria named Drug Discovery of the Year 2021

02 Mar 2021

The Alnylam Pharmaceuticals team has been recognised by the British Pharmacological Society for the development of Givosiran (Givlaari™) with its prestigious annual award. 

Society endorses Cancer Research UK's ‘Creating Time for Research’ report

25 Feb 2021

The Society has endorsed a new report from Cancer Research UK, which sets out how healthcare staff can be supported to conduct research. Embedding research into care within the NHS will improve patient outcomes and support the government’s ambitions for the UK to be a ‘global science superpower’. The report, which is also endorsed by the Association of the British Pharmaceutical Industry (ABPI), the Royal College of Physicians (RCP) and others, makes nine key recommendations that address long-standing barriers to research.